Studies

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor…

This is a study to evaluate the efficacy and safety of AZD0780 in adults with clinical ASCVD or who are at risk for a first ASCVD event and…

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to…

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight…

The Transform trial is utilizing CCTA technology to develop a plaque staging software system for asymptomatic individuals at increased risk…

This trial is looking at the medication Omecamtiv Mecarbil (OM for short) in patients with severely reduced ejection fraction (pumping…

This study is looking at a once daily pill (PF-07976016) in combination with Liraglutide which is an approved GLP-1R agonist in patients…

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia…

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with…

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…

The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and chronic…